(Q42674455)

4 November 2017

title

Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder (English)

1 reference

major depressive disorder

4 November 2017

1 reference

1 reference

obsessive-compulsive disorder

inferred from title

1 reference

1 reference

Robert L Findling

1

1 reference

4 November 2017

Gianluca Nucci

2

1 reference

4 November 2017

Antoni A Piergies

3

1 reference

4 November 2017

Roberto Gomeni

4

1 reference

4 November 2017

Edward I Bartolic

5

1 reference

4 November 2017

Regan Fong

6

1 reference

4 November 2017

David J Carpenter

7

1 reference

4 November 2017

J Steven Leeder

8

1 reference

4 November 2017

Andrea Gaedigk

9

1 reference

4 November 2017

Theodore M Danoff

10

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

4 November 2017

published in

Neuropsychopharmacology

1 reference

4 November 2017

volume

31

1 reference

4 November 2017

issue

6

1 reference

4 November 2017

page(s)

1274-1285

1 reference

Grapefruit juice-drug interactions

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: comparison with fluoxetine and quinidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Pharmacokinetics in the child

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Paroxetine pharmacokinetics in depressed children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Limited association of the 2988g > a single nucleotide polymorphism with CYP2D641 in black subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D642, in African American subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the -1584G promoter polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Changes in human whole blood 5-hydroxytryptamine (5-HT) and platelet 5-HT uptake during treatment with paroxetine, a selective 5-HT uptake inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Dysthymic disorder in clinically referred preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Spotlight on paroxetine in psychiatric disorders in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

A general model for the origin of allometric scaling laws in biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Fluoxetine pharmacokinetics in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

7 January 2021

Withdrawal symptoms associated with paroxetine discontinuation in a nine-year-old boy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

7 January 2021

Erratum: Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

7 January 2021

Paroxetine: lack of effect on hepatic drug metabolizing enzymes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

7 January 2021

A review of the metabolism and pharmacokinetics of paroxetine in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

7 January 2021

Paroxetine: Pharmacokinetics, Tolerance and Depletion of Blood 5-HT in Man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

7 January 2021

Paroxetine Steady-State Plasma Concentration in Relation to CYP2D6 Genotype in Extensive Metabolizers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

7 January 2021

The clinical pharmacology of paroxetine in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

7 January 2021

Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: Nonlinearity and relation to the sparteine oxidation polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

7 January 2021

The relationship between paroxetine and the sparteine oxidation polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300960

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300960

1 reference

Dimensions Publication ID

4 November 2017

1010264194

0 references

1 reference